Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: Finland Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20023
20032
20043
20064
20075
20083
20096
20105
20114
20123
20133
20142
20164
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S32
AstraZeneca7
Eli Lilly and Company2
Sanofi2
Takeda2
Andromeda Biotech Ltd.1
Bayer1
Diamyd Therapeutics AB1
GlaxoSmithKline1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus53
Diabetes Mellitus, Type 233
Diabetes Mellitus, Type 117
Glucose Metabolism Disorders4
Metabolic Diseases3
Endocrine System Diseases2
Acute Coronary Syndrome1
Coronary Artery Disease1
Diabetic Neuropathies1
Dyslipidemias1

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.